Amphenidone

This classification denotes a sedative and hypnotic with the molecular formula C11H10N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M61FM2VCSV, chemically known as 2(1h)-pyridone, 1-(m-aminophenyl)- but generally known as amphenidone, which bears US NIH Compound Identifier 8641. European Medicines Agency schedules Amphenidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05484MIG. The term AMPHENIDONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). AMPHENIDONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amphenidone under HS 29337900 and SITC 51561. As of Q4 2014, AMPHENIDONE remains the US FDA Preferred Term for this commodity. Amphenidone bears US NLM identifiers UMLS ID C2698099 and NCI Concept Code C76934. SMILES: C1=CC(=O)N(C=C1)C2=CC(=CC=C2)N.